(Q37801382)

23 August 2017

Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma (English)

1 reference

23 August 2017

6

Ola Landgren

1 reference

23 August 2017

1

Sham Mailankody

1 reference

23 August 2017

Esther Mena

2

1 reference

23 August 2017

Constance M Yuan

series ordinal

3

1 reference

23 August 2017

Arun Balakumaran

series ordinal

4

1 reference

23 August 2017

W Michael Kuehl

series ordinal

5

1 reference

23 August 2017

language of work or name

1 reference

20 October 2010

1 reference

23 August 2017

1 reference

23 August 2017

51

1 reference

23 August 2017

12

1 reference

23 August 2017

2159-2170

1 reference

23 August 2017

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Improved survival in multiple myeloma and the impact of novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Prevalence of monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

A comparative study of monoclonal gammopathies and immunoglobulin levels in Japanese and United States elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

A monoclonal gammopathy precedes multiple myeloma in most patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Multiple myeloma: evolving genetic events and host interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Clinical and biological significance of RAS mutations in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Mining gene expression profiles: expression signatures as cancer phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Global Gene Expression Profiling in the Study of Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

microRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

MicroRNAs modulate hematopoietic lineage differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Worms gang up on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

DNA methylation profiles of lymphoid and hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Value of FDG PET in the assessment of patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Skeletal PET with 18F-fluoride: applying new technology to an old tracer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Induction of angiogenesis during the transition from hyperplasia to neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Recurring mutations found by sequencing an acute myeloid leukemia genome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

A comprehensive catalogue of somatic mutations from a human cancer genome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.525725

Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases

21 January 2018

1 reference

12 December 2020

Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases

1 reference

12 December 2020

Angiogenesis in hematologic malignancies

1 reference

12 December 2020

Chromosomal abnormalities clustering in multiple myeloma reveals cytogenetic subgroups with nonrandom acquisition of chromosomal changes

1 reference

12 December 2020

Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.

1 reference

12 December 2020

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation

1 reference

12 December 2020

Genomic abnormalities in monoclonal gammopathy of undetermined significance

1 reference

12 December 2020

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Identifies a Subgroup of Patients with Asymptomatic Monoclonal Plasma Cell Disease and Pathologic Microcirculation

1 reference

12 December 2020

Long-term follow-up of IgM monoclonal gammopathy of undetermined significance

1 reference

12 December 2020

Aberrant gene promoter methylation in plasma cell dyscrasias

1 reference

12 December 2020

Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance

1 reference

12 December 2020

DNA methylation analysis of tumor suppressor genes in monoclonal gammopathy of undetermined significance

1 reference

12 December 2020

Fluorodeoxyglucose positron emission tomography in multiple myeloma, solitary plasmocytoma and monoclonal gammapathy of unknown significance

1 reference

12 December 2020

Methylation of p15 and p16 genes in acute promyelocytic leukemia: potential diagnostic and prognostic significance

1 reference

12 December 2020

The fundamental role of epigenetic events in cancer

1 reference

12 December 2020

10.3109/10428194.2010.525725

Identifiers

DOI

1 reference

23 August 2017

1 reference